Marples D, Frøkiaer J, Knepper M A, Nielsen S
Department of Physiology, University of Leeds, England, United Kingdom.
Proc Assoc Am Physicians. 1998 Sep-Oct;110(5):401-6.
A series of recent studies have demonstrated that expression of aquaporin-2 (AQP2), the vasopressin-regulated water channel of the kidney collecting duct, is greatly reduced in acquired forms of nephrogenic diabetes insipidus (NDI). In some forms of NDI, there is also impaired delivery of these channels to the apical plasma membrane, where they permit water reabsorption from the urine. The combination of these factors is likely to underlie the urinary concentrating defect that defines these conditions. Direct infusion of vasopressin causes an increase in AQP2 expression, probably via a rise in cytosolic adenosine 3:5-cyclic phosphate, which also acts as the second messenger, triggering the delivery of AQP2 to the plasma membrane. However, it is clear from the studies described that there are also vasopressin-independent pathways that regulate the expression of AQP2, some of which appear to reflect intranephric changes, whereas others involve systemic signals. These studies also show that recovery of AQP2 expression, even after correction of the underlying condition, can be slow, consistent with the clinical observation that recovery of urinary-concentrating ability often takes weeks or months. An understanding of the cellular signals and mechanisms responsible for the decrease in AQP2 expression may make it possible to develop treatments for this common clinical problem.
一系列近期研究表明,在获得性肾性尿崩症(NDI)中,肾集合管中血管加压素调节的水通道蛋白2(AQP2)的表达大幅降低。在某些形式的NDI中,这些通道向顶端质膜的转运也受损,而在顶端质膜处这些通道可使水从尿液中重吸收。这些因素的综合作用可能是导致这些病症出现尿浓缩功能缺陷的原因。直接输注血管加压素可能通过胞质环磷酸腺苷3:5-单磷酸(cAMP)水平升高,进而使AQP2表达增加,cAMP也作为第二信使,触发AQP2转运至质膜。然而,从所描述的研究中可以明确,也存在不依赖血管加压素的途径来调节AQP2的表达,其中一些途径似乎反映了肾内变化,而其他途径涉及全身信号。这些研究还表明,即使在潜在病症得到纠正后,AQP2表达的恢复也可能较慢,这与尿浓缩能力恢复通常需要数周或数月的临床观察结果一致。了解导致AQP2表达降低的细胞信号和机制,可能有助于开发针对这一常见临床问题的治疗方法。